Stock A086820 BIO SOLUTION CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Bio Solution Co.,Ltd.

Equities

A086820

KR7086820008

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
19,580 KRW +10.31% Intraday chart for Bio Solution Co.,Ltd. +19.17% +0.98%
2023 Helixmith Co., Ltd announced that it has received KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd. CI
2023 Helixmith Co., Ltd announced that it expects to receive KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd. CI

Business Summary

Bio Solution Co.,Ltd. is a Korea based company mainly engaged in the manufacturing and distribution of cell therapy products. The Company manufactures and sells cell based cosmetic raw materials and therapeutics with background in somatic and stem cell technology. The Company’s major products include cosmetic raw material called stem water, which contains human stem cells has whitening and anti-wrinkling effects; as well as keratinocyte medication for severe burns and chondrocyte therapy product used to cure arthritis. The Company also researches and develops human tissue models for toxicity and efficacy testing using tissue engineering technology.

Number of employees: 71

Sales per Business

KRW in Million2022Weight2023Weight Delta
Cell Therapy
80.6 %
7,528 74.5 % 10,047 80.6 % +33.46%
Other
11.2 %
1,094 10.8 % 1,393 11.2 % +27.34%
Stem Number, etc.
8.2 %
1,480 14.7 % 1,022 8.2 % -30.93%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
97.8 %
9,604 95.1 % 12,184 97.8 % +26.86%
Overseas
2.2 %
498 4.9 % 278 2.2 % -44.21%

Managers

Managers TitleAgeSince
Song-Sun Chang CEO
 Chief Executive Officer 67 -
Ji-Wook Jeong DFI
 Director of Finance/CFO 56 -
Jung-Sun Lee CTO
 Chief Tech/Sci/R&D Officer 52 -
Gwang-Yeop Jin AUD
 Comptroller/Controller/Auditor 63 -

Members of the board

Members of the board TitleAgeSince
Song-Sun Chang CEO
 Chief Executive Officer 67 -
Jae-Soon Park BRD
 Director/Board Member 68 -
Nam-Moon Kim BRD
 Director/Board Member 72 -
Jung-Sun Lee CTO
 Chief Tech/Sci/R&D Officer 52 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,143,426 6,499,604 ( 79.81 %) 119,808 ( 1.471 %) 79.81 %

Shareholders

NameEquities%Valuation
Song-Sun Chang
17.50 %
1,424,881 17.50 % 18 M ₩
BIO SOLUTION CO.,LTD.
1.471 %
119,808 1.471 % 2 M ₩
Jung-Sun Lee
0.7982 %
65,000 0.7982 % 831 903 ₩
Hye-su Jang
0.3446 %
28,063 0.3446 % 359 165 ₩
Bio Solution Co. Ltd. ESOA
0.0745 %
6,070 0.0745 % 77 687 ₩

Holdings

NameEquities%Valuation
HELIXMITH CO., LTD
15.22%
 7,467,405 15.22% 24,711,062 $
BIO SOLUTION CO.,LTD.
1.47%
 119,808 1.47% 1,533,364 $

Company contact information

Bio Solution Co., Ltd.

Unit803, Seoul Techno-Park 232 Gongneung-ro

01811, Seoul

+

http://www.biosolutions.co.kr
address Bio Solution Co.,Ltd.(A086820)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
BIO SOLUTION CO.,LTD. Stock Bio Solution Co.,Ltd.
+0.98% 103M
CSL LIMITED Stock CSL Limited
-5.99% 84.46B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.85B
BIOGEN INC. Stock Biogen Inc.
-25.38% 27.69B
UCB Stock UCB
+53.61% 24.28B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-8.40% 17.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-33.74% 13.67B
INCYTE CORPORATION Stock Incyte Corporation
-17.03% 11.86B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.19% 11.79B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
-2.25% 8.07B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A086820 Stock
  4. Company Bio Solution Co.,Ltd.